Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives

Rafael Simó, Cristina Hernández

Research output: Contribution to journalReview articleResearchpeer-review

293 Citations (Scopus)


Diabetic retinopathy (DR), one of the leading causes of preventable blindness, has been considered a microcirculatory disease of the retina. However, there is emerging evidence to suggest that retinal neurodegeneration is an early event in the pathogenesis of DR, which participates in the development of microvascular abnormalities. Therefore, the study of the underlying mechanisms leading to neurodegeneration and the identification of the mediators in the crosstalk between neurodegeneration and microangiopathy will be essential for the development of new therapeutic strategies. In this review, an updated discussion of the mechanisms involved in neurodegeneration, as well as the link between neurodegeneration and microangiopathy, is presented. Finally, the therapeutic implications and new perspectives based on identifying those patients with retinal neurodegeneration are given. © 2013 Elsevier Ltd.
Original languageEnglish
Pages (from-to)23-33
JournalTrends in Endocrinology and Metabolism
Issue number1
Publication statusPublished - 1 Jan 2014


  • Diabetic microangiopathy
  • Diabetic retinopathy
  • Eye drops
  • Neurodegeneration
  • Neuroprotection
  • Neurovascular unit


Dive into the research topics of 'Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives'. Together they form a unique fingerprint.

Cite this